Cargando…
Aptamers as promising nanotheranostic tools in the COVID‐19 pandemic era
The emergence of SARS‐COV‐2, the causative agent of new coronavirus disease (COVID‐19) has become a pandemic threat. Early and precise detection of the virus is vital for effective diagnosis and treatment. Various testing kits and assays, including nucleic acid detection methods, antigen tests, sero...
Autores principales: | Dzuvor, Christian K. O., Tettey, Ebenezer Larteh, Danquah, Michael K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111085/ https://www.ncbi.nlm.nih.gov/pubmed/35238490 http://dx.doi.org/10.1002/wnan.1785 |
Ejemplares similares
-
One stone, many birds: Recent advances in functional nanogels for cancer nanotheranostics
por: Wang, Huiyi, et al.
Publicado: (2022) -
Generating Cell Targeting Aptamers for Nanotheranostics Using Cell-SELEX
por: Lyu, Yifan, et al.
Publicado: (2016) -
Anti-SARS-CoV-1 and −2 nanobody engineering towards avidity-inspired therapeutics
por: Obeng, Eugene M., et al.
Publicado: (2022) -
Gold Nanotheranostics: Proof-of-Concept or Clinical Tool?
por: Pedrosa, Pedro, et al.
Publicado: (2015) -
Engineered Aptamers for Enhanced COVID-19 Theranostics
por: Acquah, Caleb, et al.
Publicado: (2021)